|Videos|December 20, 2022
Interview with Anthony Carpanzano (AAPS 2022)
Author(s)Chris Spivey
Anthony Carpanzano, Director of R&D at JRS Pharma, discussed ongoing formulation challenges and trends.
KEY LEARNING OBJECTIVES
- Overcoming formulation challenges in converting liquids into solid dose,
- Turning soft gel into tablets, enhancing dissolution,
- Simplifying modified-release formulations
Related Content
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
3
Everything to Know about BMS & NVidia’s AI Supercomputer
4
PharmTech Weekly Roundup—July 17, 2026
5